Stock-based compensation (Tables)

6 Months Ended

Jun. 30, 2025

Share-Based Payment Arrangement [Abstract]

Schedule of Stock-based Compensation Expense Recorded in Consolidated Statements of Operations

Stock-based compensation is classified as follows in the accompanying condensed consolidated statements of operations for the three and six months ended June 30, 2025 and 2024 (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
Cost of revenues, genomics	$	1,420	$	11,327	$	2,455	$	11,327
Cost of revenues, data and services		693		7,229		1,304		7,229
Technology research and development		3,285		50,434		6,604		50,434
Research and development		2,335		42,233		4,317		42,233
Selling, general and administrative		14,722		377,090		30,749		377,090
Total stock-based compensation	$	22,455	$	488,313	$	45,429	$	488,313